Benefits of synTQ for biotech companies under the spotlight at Festival of Biologics USA
The Festival of Biologics offers a valuable forum for pharmaceutical and biotechnology companies, academics, research institutes as well as leading players across the entire value chain. During the event, participants discuss technologies, strategies and trends in clinical trials, manufacturing and commercial aspects involved in bringing new therapies to market.
With one of the biggest challenges for companies being the quick, efficient as well as cost-effective development and production of competitive, high-quality drugs, the adoption of solutions that can address these issues can be game changing. PAT can offer exactly this whilst futureproofing operations, in line with smart manufacturing and Pharma 4.0 frameworks.
As a prominent expert in PAT, offering a market-leading platform, Optimal will contribute to the discussion, highlighting what the technology can offer and how it can improve R&D, manufacturing, quality control and assurance operations. More precisely, visitors to Optimal’s stand will be able to gain an insight on how (bio)pharmaceutical companies worldwide have benefitted from PAT and synTQ.
Martin Gadsby, VP at Optimal Industrial Technologies, comments: “Biologics is an extremely challenging sector, as it needs to deliver innovative medicaments and therapies while meeting stringent regulations. Nonetheless, PAT can make it easier for companies to be highly successful, as proven by key applications of synTQ by over half of the major global biopharmaceutical companies. We invite anyone interested in improving productivity, efficiency and flexibility within their facilities to talk to our experts at the Festival of Biologics USA.”
Visit Optimal on booth 62 at the Festival of Biologics USA on 20th – 22nd March 2023, at Sheraton San Diego Marina, San Diego, CA, U.S., by registering at: https://www.terrapinn.com/conference/festival-of-biologics-usa/
Image 1: Optimal will showcase the competitive advantages that Process Analytical Technology (PAT) can bring to drug discovery, development, manufacturing and market access in biopharma at the Festival of Biologics USA.
Within the Optimal group, we have more than 30 years’ experience in the automation and optimisation of control and data management systems for the food, chemical, pharmaceutical, biotech, life science and other process industries.
The demands being placed on manufacturers in relation to getting products to market sooner, minimising development and production costs together with increasing product quality and business sustainability are ever increasing. Our primary aim is to deliver measurable improvements in all these target areas.
In addition to practical automation and system integration expertise, Optimal Industrial Technologies has also developed the world-leading PAT Knowledge Management software platform – synTQ® – which is used by over 60% of the world’s leading pharmaceutical and biotech companies, and is now being adopted by other process industries. synTQ has been a proven enabler of QbD via PAT by significantly increasing productivity and quality, while reducing waste, time to manufacture and time to market for batch and continuous processes.
Editorial Contact: Chiara Civardi
Tel: +44 (0)1905 917477
Web: news.dmaeuropa.com
Email: [email protected]
Address: Progress House, Midland Road, Worcester, Worcestershire, WR5 1AQ, United Kingdom
Reader Contact:
Optimal Industrial Technologies: Martin Gadsby
Tel: +44 (0) 1173 742 222
Web: https://www.optimal-tech.co.uk
Email: [email protected]
Address: 5 Monarch Close, Emersons Green, Bristol, BS16 7FH, United Kingdom